186 related articles for article (PubMed ID: 9532339)
21. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
[TBL] [Abstract][Full Text] [Related]
22. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
23. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
[TBL] [Abstract][Full Text] [Related]
24. Graves' disease following subacute thyroiditis.
Nakano Y; Kurihara H; Sasaki J
Tohoku J Exp Med; 2011 Dec; 225(4):301-9. PubMed ID: 22112923
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis of autoimmune thyroid disease].
Trbojević B; Djurica S
Srp Arh Celok Lek; 2005 Oct; 133 Suppl 1():25-33. PubMed ID: 16405253
[TBL] [Abstract][Full Text] [Related]
26. Treatment of post-partum thyrotoxicosis.
Azizi F
J Endocrinol Invest; 2006 Mar; 29(3):244-7. PubMed ID: 16682838
[TBL] [Abstract][Full Text] [Related]
27. Increase in antideoxyribonucleic acid antibody titer in postpartum aggravation of autoimmune thyroid disease.
Tachi J; Amino N; Iwatani Y; Tamaki H; Mori M; Aozasa M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1988 Nov; 67(5):1049-53. PubMed ID: 3263380
[TBL] [Abstract][Full Text] [Related]
28. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
Ginsberg J; von Westarp C
CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
[TBL] [Abstract][Full Text] [Related]
29. Radioiodine therapy for Graves' disease: case selection and restrictions recommended to patients in North America.
Wartofsky L
Thyroid; 1997 Apr; 7(2):213-6. PubMed ID: 9133687
[TBL] [Abstract][Full Text] [Related]
30. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
[TBL] [Abstract][Full Text] [Related]
31. Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy.
Hidaka Y; Tamaki H; Iwatani Y; Tada H; Mitsuda N; Amino N
Clin Endocrinol (Oxf); 1994 Jul; 41(1):15-20. PubMed ID: 7914152
[TBL] [Abstract][Full Text] [Related]
32. Important considerations in the management of Graves' disease in pregnant women.
Okosieme OE; Lazarus JH
Expert Rev Clin Immunol; 2015; 11(8):947-57. PubMed ID: 26041458
[TBL] [Abstract][Full Text] [Related]
33. Graves' Disease Pharmacotherapy in Women of Reproductive Age.
Prunty JJ; Heise CD; Chaffin DG
Pharmacotherapy; 2016 Jan; 36(1):64-83. PubMed ID: 26799350
[TBL] [Abstract][Full Text] [Related]
34. Graves' hyperthyroidism after postpartum thyroiditis.
Shorey S; Badenhoop K; Walfish PG
Thyroid; 1998 Dec; 8(12):1117-22. PubMed ID: 9920367
[TBL] [Abstract][Full Text] [Related]
35. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology, management and outcomes of Graves' disease-real life data.
Hussain YS; Hookham JC; Allahabadia A; Balasubramanian SP
Endocrine; 2017 Jun; 56(3):568-578. PubMed ID: 28478488
[TBL] [Abstract][Full Text] [Related]
37. [Reflections on the therapeutic goal in Basedow hyperthyroidism].
Höfer R
Acta Med Austriaca; 1987; 14(3-4):70-2. PubMed ID: 2447737
[TBL] [Abstract][Full Text] [Related]
38. Comparison of curative effect of 131I and antithyroid drugs in Graves' disease: a meta-analysis.
Yuan J; Lu X; Yue Y
Minerva Endocrinol; 2018 Dec; 43(4):511-516. PubMed ID: 28252265
[TBL] [Abstract][Full Text] [Related]
39. New-onset Graves' disease in the postpartum period.
Goldstein AL
J Midwifery Womens Health; 2013; 58(2):211-4. PubMed ID: 23590488
[TBL] [Abstract][Full Text] [Related]
40. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
